13 Jeremy Grantham Jazz Pharmaceuticals plc Trades
Jeremy Grantham's position in Jazz Pharmaceuticals plc is currently worth $22.8 Million. That's 0.10% of their equity portfolio (142nd largest holding). The first Jazz Pharmaceuticals plc trade was made in Q4 2020. Since then Jeremy Grantham bought shares eight more times and sold shares on four occasions. The investor's estimated purchase price is $31.3 Million, resulting in a loss of 27%.
Avg closing price
Price range
Increased shares by 13.7% (+25.1 Thousand shares)
Q4 2023
Avg closing price
$124.79
Price range
$114.26
-
$136.00
Sold 0.7% shares (-1.3 Thousand shares)
Q3 2023
Avg closing price
$133.25
Price range
$122.00
-
$145.31
Sold 19.6% shares (-44.7 Thousand shares)
Q2 2023
Avg closing price
$134.55
Price range
$122.50
-
$147.16
Sold 1.3% shares (-2.9 Thousand shares)
Q1 2023
Avg closing price
$147.92
Price range
$133.98
-
$160.47
Increased shares by 14.7% (+29.6 Thousand shares)
Q4 2022
Avg closing price
$146.56
Price range
$129.72
-
$159.85
Increased shares by 2.6% (+5.1 Thousand shares)
Q3 2022
Avg closing price
$152.05
Price range
$126.59
-
$161.18
Sold 2.4% shares (-4.8 Thousand shares)
Q2 2022
Avg closing price
$153.94
Price range
$141.59
-
$168.66
Increased shares by 12.3% (+22.1 Thousand shares)
Q1 2022
Avg closing price
$145.12
Price range
$129.64
-
$160.70
Increased shares by 1.8% (+3.1 Thousand shares)
Q4 2021
Avg closing price
$131.42
Price range
$119.87
-
$145.67
Increased shares by 19.3% (+28.6 Thousand shares)
Q3 2021
Avg closing price
$151.09
Price range
$128.64
-
$184.79
Increased shares by 25.6% (+30.1 Thousand shares)
Q2 2021
Avg closing price
$173.22
Price range
$160.20
-
$186.42
Increased shares by 30.6% (+27.6 Thousand shares)
Q1 2021
Avg closing price
$164.55
Price range
$150.19
-
$173.50
New holding (+90.2 Thousand shares)
Q4 2020
Avg closing price
$148.94
Price range
$140.71
-
$165.05
